IBDEI10W ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16448,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,16449,0)
 ;;=D63.8^^88^879^22
 ;;^UTILITY(U,$J,358.3,16449,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16449,1,3,0)
 ;;=3^Anemia in Chronic Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,16449,1,4,0)
 ;;=4^D63.8
 ;;^UTILITY(U,$J,358.3,16449,2)
 ;;=^5002343
 ;;^UTILITY(U,$J,358.3,16450,0)
 ;;=C22.3^^88^879^27
 ;;^UTILITY(U,$J,358.3,16450,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16450,1,3,0)
 ;;=3^Angiosarcoma of Liver
 ;;^UTILITY(U,$J,358.3,16450,1,4,0)
 ;;=4^C22.3
 ;;^UTILITY(U,$J,358.3,16450,2)
 ;;=^5000936
 ;;^UTILITY(U,$J,358.3,16451,0)
 ;;=D61.9^^88^879^28
 ;;^UTILITY(U,$J,358.3,16451,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16451,1,3,0)
 ;;=3^Aplastic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,16451,1,4,0)
 ;;=4^D61.9
 ;;^UTILITY(U,$J,358.3,16451,2)
 ;;=^5002342
 ;;^UTILITY(U,$J,358.3,16452,0)
 ;;=D56.1^^88^879^30
 ;;^UTILITY(U,$J,358.3,16452,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16452,1,3,0)
 ;;=3^Beta Thalassemia
 ;;^UTILITY(U,$J,358.3,16452,1,4,0)
 ;;=4^D56.1
 ;;^UTILITY(U,$J,358.3,16452,2)
 ;;=^340495
 ;;^UTILITY(U,$J,358.3,16453,0)
 ;;=C83.79^^88^879^32
 ;;^UTILITY(U,$J,358.3,16453,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16453,1,3,0)
 ;;=3^Burkitt Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,16453,1,4,0)
 ;;=4^C83.79
 ;;^UTILITY(U,$J,358.3,16453,2)
 ;;=^5001600
 ;;^UTILITY(U,$J,358.3,16454,0)
 ;;=C83.70^^88^879^33
 ;;^UTILITY(U,$J,358.3,16454,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16454,1,3,0)
 ;;=3^Burkitt Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,16454,1,4,0)
 ;;=4^C83.70
 ;;^UTILITY(U,$J,358.3,16454,2)
 ;;=^5001591
 ;;^UTILITY(U,$J,358.3,16455,0)
 ;;=D09.0^^88^879^40
 ;;^UTILITY(U,$J,358.3,16455,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16455,1,3,0)
 ;;=3^Carcinoma in Situ of Bladder
 ;;^UTILITY(U,$J,358.3,16455,1,4,0)
 ;;=4^D09.0
 ;;^UTILITY(U,$J,358.3,16455,2)
 ;;=^267742
 ;;^UTILITY(U,$J,358.3,16456,0)
 ;;=D06.9^^88^879^41
 ;;^UTILITY(U,$J,358.3,16456,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16456,1,3,0)
 ;;=3^Carcinoma in Situ of Cervix
 ;;^UTILITY(U,$J,358.3,16456,1,4,0)
 ;;=4^D06.9
 ;;^UTILITY(U,$J,358.3,16456,2)
 ;;=^5001941
 ;;^UTILITY(U,$J,358.3,16457,0)
 ;;=D06.0^^88^879^43
 ;;^UTILITY(U,$J,358.3,16457,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16457,1,3,0)
 ;;=3^Carcinoma in Situ of Endocervix
 ;;^UTILITY(U,$J,358.3,16457,1,4,0)
 ;;=4^D06.0
 ;;^UTILITY(U,$J,358.3,16457,2)
 ;;=^5001938
 ;;^UTILITY(U,$J,358.3,16458,0)
 ;;=D06.1^^88^879^44
 ;;^UTILITY(U,$J,358.3,16458,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16458,1,3,0)
 ;;=3^Carcinoma in Situ of Exocervix
 ;;^UTILITY(U,$J,358.3,16458,1,4,0)
 ;;=4^D06.1
 ;;^UTILITY(U,$J,358.3,16458,2)
 ;;=^5001939
 ;;^UTILITY(U,$J,358.3,16459,0)
 ;;=D06.7^^88^879^42
 ;;^UTILITY(U,$J,358.3,16459,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16459,1,3,0)
 ;;=3^Carcinoma in Situ of Cervix,Other Parts
 ;;^UTILITY(U,$J,358.3,16459,1,4,0)
 ;;=4^D06.7
 ;;^UTILITY(U,$J,358.3,16459,2)
 ;;=^5001940
 ;;^UTILITY(U,$J,358.3,16460,0)
 ;;=D04.9^^88^879^45
 ;;^UTILITY(U,$J,358.3,16460,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16460,1,3,0)
 ;;=3^Carcinoma in Situ of Skin
 ;;^UTILITY(U,$J,358.3,16460,1,4,0)
 ;;=4^D04.9
 ;;^UTILITY(U,$J,358.3,16460,2)
 ;;=^5001925
 ;;^UTILITY(U,$J,358.3,16461,0)
 ;;=C91.11^^88^879^48
 ;;^UTILITY(U,$J,358.3,16461,1,0)
 ;;=^358.31IA^4^2
